Pharmacogenomics of Open-Angle Glaucoma

By  

Current Pharmacogenomics and Personalized Medicine (Formerly Current Pharmacogenomics), Vol. 6, Iss. 2, 2008-06 ,pp. : 121-125

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacological Management of Primary Open-Angle Glaucoma: Second-Line Options and Beyond

By Webers Carroll A.B.   Beckers Henny J.M.   Nuijts Rudy M.M.A.   Schouten Jan S.A.G.  

Drugs & Aging, Vol. 25, Iss. 9, 2008-01 ,pp. : 729-759

Adis International

Access to resources Recommend Favorite

Brinzolamide: A Review of Its Use in the Management of Primary Open-Angle Glaucoma and Ocular Hypertension

By Cvetkovic R.S.   Perry C.M.  

Drugs & Aging, Vol. 20, Iss. 12, 2003-01 ,pp. : 919-947

Adis International

Access to resources Recommend Favorite

Safety of Unoprostone Isopropyl as Mono- or Adjunctive Therapy in Patients with Primary Open-Angle Glaucoma or Ocular Hypertension

By Mello P.A.d.A.  

Drug Safety, Vol. 25, Iss. 8, 2002-01 ,pp. : 583-597

Adis International

Access to resources Recommend Favorite

Cost-Minimisation Study of Dorzolamide versus Brinzolamide in the Treatment of Ocular Hypertension and Primary Open-Angle Glaucoma: In Four European Countries

By Rouland J.  

PharmacoEconomics, Vol. 21, Iss. 3, 2003-01 ,pp. : 201-213

Adis International

Access to resources Recommend Favorite